Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
4 clinical trials · Condition
◉ Watch Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| Cancer and Blood Pressure Management, CARISMA Study (NCT04467021) | ECOG-ACRIN Cancer Research Group | 2020-10-29 |
| Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management (NCT04216732) | M.D. Anderson Cancer Center | 2020-01-10 |
| Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers (NCT04106843) | M.D. Anderson Cancer Center | 2019-06-13 |
Track Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.